Steve R Siegal1, James P Dolan2, Elizabeth N Dewey3, Alexander R Guimaraes4, Brandon H Tieu5, Paul H Schipper6, John G Hunter7. 1. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: siegal@ohsu.edu. 2. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: dolanj@ohsu.edu. 3. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: deweye@ohsu.edu. 4. Oregon Health & Science University, Department of Diagnostic Radiology, 3181 SW Sam Jackson Park Road, Mail Code 340, Portland, OR 97239, USA. Electronic address: guimaraa@ohsu.edu. 5. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: tieub@ohsu.edu. 6. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: schippep@ohsu.edu. 7. Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA. Electronic address: hunter@ohsu.edu.
Abstract
BACKGROUND: Sarcopenia is associated with increased morbidity and mortality in hepatic, pancreatic and colorectal cancer. We examined the effect of sarcopenia on morbidity, mortality, and recurrence after resection for esophageal cancer. METHODS: Retrospective review of consecutive esophagectomies from 2010 to 2015. Computed tomography studies were analyzed for sarcopenia. Morbidity was analyzed using Fischer's test and survival data with Kaplan Meier curves. RESULTS: The sarcopenic group (n = 127) had lower BMI, later stage disease, and higher incidence of neoadjuvant radiation than those without sarcopenia (n = 46). There were no differences in morbidity or mortality between the groups (p = .75 and p = .31, respectively). Mean length of stay was similar (p = .70). Disease free and overall survival were similar (p = .20 and p = .39, respectively). CONCLUSION: There is no association between sarcopenia and increased morbidity, mortality and disease-free survival in patients undergoing esophagectomy for cancer. Sarcopenia in esophageal cancer may not portend worse outcomes that have been reported in other solid tumors.
BACKGROUND:Sarcopenia is associated with increased morbidity and mortality in hepatic, pancreatic and colorectal cancer. We examined the effect of sarcopenia on morbidity, mortality, and recurrence after resection for esophageal cancer. METHODS: Retrospective review of consecutive esophagectomies from 2010 to 2015. Computed tomography studies were analyzed for sarcopenia. Morbidity was analyzed using Fischer's test and survival data with Kaplan Meier curves. RESULTS: The sarcopenic group (n = 127) had lower BMI, later stage disease, and higher incidence of neoadjuvant radiation than those without sarcopenia (n = 46). There were no differences in morbidity or mortality between the groups (p = .75 and p = .31, respectively). Mean length of stay was similar (p = .70). Disease free and overall survival were similar (p = .20 and p = .39, respectively). CONCLUSION: There is no association between sarcopenia and increased morbidity, mortality and disease-free survival in patients undergoing esophagectomy for cancer. Sarcopenia in esophageal cancer may not portend worse outcomes that have been reported in other solid tumors.
Authors: Camila T B Gabiatti; Mariane C L Martins; Daniela L Miyazaki; Leandro P Silva; Fabiana Lascala; Ligia T Macedo; Maria Carolina Santos Mendes; José Barreto Campello Carvalheira Journal: Cancer Med Date: 2019-10-01 Impact factor: 4.452
Authors: Connor J Wakefield; Fadi Hamati; Justin M Karush; Andrew T Arndt; Nicole Geissen; Michael J Liptay; Jeffrey A Borgia; Sanjib Basu; Christopher W Seder Journal: J Thorac Dis Date: 2021-02 Impact factor: 2.895
Authors: Lucy X Ma; Kirsty Taylor; Osvaldo Espin-Garcia; Reut Anconina; Chihiro Suzuki; Michael J Allen; Marta Honorio; Yvonne Bach; Frances Allison; Eric X Chen; Savtaj Brar; Carol J Swallow; Jonathan Yeung; Gail E Darling; Rebecca Wong; Sangeetha N Kalimuthu; Raymond W Jang; Patrick Veit-Haibach; Elena Elimova Journal: Cancer Med Date: 2020-12-09 Impact factor: 4.452